Sea You at Fetch Long Beach
News|Articles|October 21, 2026

Wedgewood recalls nearly 4000 compounded veterinary products over drug potency concerns

Medications shipped nationwide from February through early October may contain too little or too much active drug. The company has reported 98 complaints to date—7 of them serious.

Wedgewood Pharmacy LLC is voluntarily recalling nearly 4000 compounded veterinary products that may contain too much or too little of their active ingredients.1,2 The count refers to individual product listings, not the total number of affected lots.

According to a news release by Wedgewood, the issue was discovered through the company's own quality processes. The company said inconsistencies in the reliability of laboratory testing data could have resulted in products with incorrect potency.

The Swedesboro, New Jersey-based compounding pharmacy announced the recall on October 21, 2026. The affected medications, all still within their expiration dates, were shipped to veterinary practices, pharmacies, and other customers across the US between February 18 and October 6, 2026. Wedgewood said the recall is being conducted with the knowledge of the FDA.

The recall covers multiple dosage forms, concentrations, and sizes.2 The products include powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, and topical sprays and gels. The medications are compounded for use in companion, equine, exotic, zoo, wildlife, and aquatic animals and are not intended for food-producing animals.

Searchable recall list

Wedgewood has posted a dedicated recall lookup page with a search bar that allows users to search for recalled products by name or stock keeping unit (SKU) and check associated lot numbers and expiration dates.2 Users can search by partial product names or SKUs, and the results list lot numbers in numerical order with expiration dates.

Potential health risks

According to Wedgewood, a subpotent product can result in ineffective treatment, and a superpotent product can cause toxicity or overdose. The company reported receiving 98 complaints to date, including 7 of them classified as serious. Wedgewood did not provide details about the complaints or identify the products involved in the complaints.1

The company is advising that animal owners with medical concerns contact their veterinarians.

Guidance for veterinary practices and pharmacies

Wedgewood is advising businesses to check their products for potentially affected lots.

"Veterinary practices, pharmacies and other customers should immediately examine their inventory, quarantine any affected product and contact Wedgewood's recall services by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET," the company wrote.1

Veterinary practices and pharmacies that dispensed affected products should identify and notify the customers who received them about the recall, Wedgewood said.

According to Wedgewood, the company has hired Sedgwick, a third-party provider of claims and recall management services, to coordinate the recall. Sedgwick is notifying affected customers by email and mail and arranging refunds or, where possible, replacement products.

Guidance for animal owners

Owners who received an affected product should stop using it, keep the product, and contact the recall services line at the same number above.

Clinical alternatives

Wedgewood said it is working with customers, veterinarians, and pet owners to identify clinically appropriate alternatives when available. Those seeking alternative treatments can call Sedgwick at 866-562-5931. Sedgwick will refer clinical questions to Wedgewood’s care team.

Adverse reactions or product quality problems can be reported to the FDA at 1-888-FDA-VETS or through the agency’s website.

Previous potency recall

Wedgewood has recalled compounded veterinary products over potency concerns before. In December 2022, Wedgewood Village Pharmacy recalled compounded omeprazole/aluminum hydroxide/magnesium hydroxide oral suspensions distributed in California, Maryland, Minnesota, New Jersey, New York and Pennsylvania because the omeprazole concentration was below the labeled amount of 2 g/30 mL.3

References

  1. Wedgewood Pharmacy issues recall of certain compounded veterinary medications within expiry due to potential potency issues. News release. Wedgewood Pharmacy LLC. October 21, 2026. Accessed October 21, 2026. https://www.prnewswire.com/news-releases/wedgewood-pharmacy-issues-recall-of-certain-compounded-veterinary-medications-within-expiry-due-to-potential-potency-issues-302915780.html
  2. Product lookup. Wedgewood Pharmacy LLC. Accessed October 21, 2026. https://www.wedgewood.com/recall-lookup/
  3. Wedgewood Village Pharmacy compounded omeprazole/aluminum hydroxide/magnesium hydroxide oral suspensions. American Veterinary Medical Association. December 15, 2022. Accessed October 21, 2026. https://www.avma.org/news/recalls-alerts/wedgewood-village-pharmacy-compounded-omeprazolealuminum-hydroxidemagnesium

Related to this article